Patents by Inventor Jürgen Volz
Jürgen Volz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230240936Abstract: The present invention relates to a heat cabin with hot air extraction. In particular, it relates to a heat cabin (10) which is equipped with a heat supply and an exhaust air system, wherein the heat cabin (10) comprises support beams (42) and cladding panels (40) and the cladding panels (40) are aligned perpendicular to a wall or ceiling normal, and the exhaust air system comprises exhaust air openings (50) in the cladding panels (40), whose shape is determined by the support beams (42) and/or the cladding panels (40) and which have no through passage parallel to the wall or ceiling normal. Furthermore, it relates to a method for operating a heat cabin.Type: ApplicationFiled: February 14, 2023Publication date: August 3, 2023Inventor: Hans-Jürgen Volz
-
Patent number: 11556045Abstract: A device for generating individual photons with energy E includes quantum emitters, having at least one determined transition with the energy E from an energy level N* to a lower energy level N1. The emitters are near a propagation path running from first to second regions. The device also includes at least one light source to output light, for propagation along the path. The light has the energy E for resonant excitation of the energy level N*. The emitters are arranged so that optionally exactly Z emitters are illuminated, forming an optical thickness ?>0 for the light along the path. The number Z lies in a range of Z0±10% and Z0 is a number at which a maximum destructive interference in the second region occurs between a two-photon component of the light scattered on the ZO emitters and a two-photon component of the non-scattered light.Type: GrantFiled: September 20, 2019Date of Patent: January 17, 2023Assignees: Humboldt-Universitaet zu Berlin, University of CopenhagenInventors: Philipp Schneeweiss, Juergen Volz, Arno Rauschenbeutel, Sahand Mahmoodian, Anders Søndberg Sørensen
-
Publication number: 20220350220Abstract: A device for generating individual photons with energy E includes quantum emitters, having at least one determined transition with the energy E from an energy level N* to a lower energy level N1. The emitters are near a propagation path running from first to second regions. The device also includes at least one light source to output light, for propagation along the path. The light has the energy E for resonant excitation of the energy level N*. The emitters are arranged so that optionally exactly Z emitters are illuminated, forming an optical thickness ?>0 for the light along the path. The number Z lies in a range of ZO±10% and ZO is a number at which a maximum destructive interference in the second region occurs between a two-photon component of the light scattered on the ZO emitters and a two-photon component of the non-scattered light.Type: ApplicationFiled: September 20, 2019Publication date: November 3, 2022Applicants: Humboldt-Universitaet zu Berlin, University of CopenhagenInventors: Philipp SCHNEEWEISS, Juergen VOLZ, Arno RAUSCHENBEUTEL, Sahand MAHMOODIAN, Anders Søndberg SØRENSEN
-
Patent number: 9952384Abstract: An optical diode (1) comprising an optical wave guide for guiding light, preferably of a light mode, with a vacuum wavelength ?0, wherein the optical wave guide has a wave guide core (2, 3, 14) with a first index of refraction (n1), and the wave guide core (2, 3, 14) is surrounded by at least one second optical medium which has at least one second index of refraction (n2), wherein n1>n2 applies, wherein the wave guide core (2, 3, 14) has at least in sections a smallest lateral dimension (7) which is a smallest dimension of a cross section (6) perpendicular to a propagation direction (5) of the light in the wave guide core (2, 3, 14), wherein the smallest lateral dimension (7) is greater than or equal to ?0/(5*n1) and less than or equal to 20*?0/n1, wherein the optical diode (1) additionally comprises at least one absorber element (10, 11, 15, 16) which is arranged in a near field, wherein the near field consists of the electromagnetic field of the light of the vacuum wavelength ?0 in the wave guide core (2Type: GrantFiled: August 18, 2015Date of Patent: April 24, 2018Assignee: Technische Universität WienInventors: Jürgen Volz, Philipp Schneeweiss, Clement Sayrin, Arno Rauschenbeutel
-
Publication number: 20170261686Abstract: An optical diode (1) comprising an optical wave guide for guiding light, preferably of a light mode, with a vacuum wavelength ?0, wherein the optical wave guide has a wave guide core (2, 3, 14) with a first index of refraction (n1), and the wave guide core (2, 3, 14) is surrounded by at least one second optical medium which has at least one second index of refraction (n2), wherein n1>n2 applies, wherein the wave guide core (2, 3, 14) has at least in sections a smallest lateral dimension (7) which is a smallest dimension of a cross section (6) perpendicular to a propagation direction (5) of the light in the wave guide core (2, 3, 14), wherein the smallest lateral dimension (7) is greater than or equal to ?0/(5*n1) and less than or equal to 20*?0/n1, wherein the optical diode (1) additionally comprises at least one absorber element (10, 11, 15, 16) which is arranged in a near field, wherein the near field consists of the electromagnetic field of the light of the vacuum wavelength ?0 in the wave guide core (2Type: ApplicationFiled: August 18, 2015Publication date: September 14, 2017Inventors: Jürgen VOLZ, Philipp SCHNEEWEISS, Clément SAYRIN, Arno RAUSCHENBEUTEL
-
Publication number: 20150266965Abstract: The present invention provides a method for preparation of a high concentration liquid formulation (HCLF) of an antibody or a fragment thereof. The present invention also relates to a method for stabilizing an anti-CD20 antibody or a fragment thereof in a liquid pharmaceutical formulation. Furthermore, the present invention relates to a liquid pharmaceutical formulation of a veltuzumab antibody or a fragment thereof comprising at least 155 mg/mL of a veltuzumab antibody or a fragment thereof.Type: ApplicationFiled: October 31, 2013Publication date: September 24, 2015Inventors: Markus Rast, Peter Skufca, Wolfram Steinhilber, Gerhard Becker, Jürgen Volz, Wolfgang Ise
-
Patent number: 9090597Abstract: The compound 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione is a novel effective inhibitor of the type 4 phosphodiesterase useful in the treatment of psoriasis or atopic dermatitis.Type: GrantFiled: August 29, 2014Date of Patent: July 28, 2015Assignee: Takeda GmbHInventors: Beate Schmidt, Christian Scheufler, Jürgen Volz, Martin Feth, Rolf-Peter Hummel, Armin Hatzelmann, Christof Zitt, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley, Deborah Ockert, Anke Heuser, Johannes A. M. Christiaans, Geert Jan Sterk, Wiro M. P. B. Menge
-
Publication number: 20140378509Abstract: The compound 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione is a novel effective inhibitor of the type 4 phosphodiesterase useful in the treatment of psoriasis or atopic dermatitis.Type: ApplicationFiled: August 29, 2014Publication date: December 25, 2014Inventors: Beate SCHMIDT, Christian SCHEUFLER, Jürgen VOLZ, Martin FETH, Rolf-Peter HUMMEL, Armin HATZELMANN, Christof ZITT, Andrea WOHLSEN, Degenhard MARX, Hans-Peter KLEY, Deborah OCKERT, Anke HEUSER, Johannes A.M. CHRISTIAANS, Geert Jan STERK, Wiro M.P.B. MENGE
-
Patent number: 8865745Abstract: The compound 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione is a novel effective inhibitor of the type 4 phosphodiesterase.Type: GrantFiled: September 14, 2012Date of Patent: October 21, 2014Assignee: Takeda GmbHInventors: Beate Schmidt, Christian Scheufler, Juergen Volz, Martin Feth, Rolf-Peter Hummel, Armin Hatzelmann, Christof Zitt, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley, Deborah Ockert, Anke Heuser, Johannes A. M. Christiaans, Geert Jan Sterk, Wiro M. P. B. Menge
-
Patent number: 8557858Abstract: A salt of (E)-N-{2-amino-phenyl)-3-{1-[4-(1-methyl-1 H-pyrazol-4-yl)-be?zenesulfonyl]-1 H-pyrrol-3-yl)-acrylamide selected from the group consisting of the hydrobromide, methansulfonate, hemi ethane-1,2-disulfonate, benzenesulfonate, toiuenesulfonate and 2-naphthalenesulfonate.Type: GrantFiled: March 11, 2009Date of Patent: October 15, 2013Assignee: 4SC AGInventors: Jürgen Volz, Martin Feth, Rolf-Peter Hummel, Matthias Müller, Thomas Maier, Bernd Müller
-
Publication number: 20130012544Abstract: The compound 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione is a novel effective inhibitor of the type 4 phosphodiesterase.Type: ApplicationFiled: September 14, 2012Publication date: January 10, 2013Applicant: NYCOMED GMBHInventors: Beate SCHMIDT, Christian SCHEUFLER, Jürgen VOLZ, Martin FETH, Rolf-Peter HUMMEL, Armin HATZELMANN, Christof ZITT, Andrea WOHLSEN, Degenhard MARX, Hans-Peter KLEY, Deborah OCKERT, Anke HEUSSR, Johannes A.M. CHRISTIAANS, Geert Jan STERK, Wiro M.P.B. MENGE
-
Patent number: 8304436Abstract: The compounds of a certain formula 1, in which R1, R7, R8, R9 and n have the meanings as given in the description, are novel effective inhibitors of the type 4 phosphodiesterase.Type: GrantFiled: May 14, 2008Date of Patent: November 6, 2012Assignee: Nycomed GmbHInventors: Beate Schmidt, Christian Scheufler, Juergen Volz, Martin Feth, Rolf-Peter Hummel, Armin Hatzelmann, Christof Zitt, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley, Deborah Ockert, Anke Heuser, Johannes A. M. Christiaans, Geert Jan Sterk, Wiro M. P. B. Menge
-
Patent number: 8232297Abstract: Compounds of a certain formula I, in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, as well as salts thereof are novel effective HDAC inhibitors.Type: GrantFiled: September 8, 2006Date of Patent: July 31, 2012Assignee: 4SC AGInventors: Thomas Maier, Thomas Beckers, Rolf-Peter Hummel, Martin Feth, Matthias Müller, Thomas Bär, Jürgen Volz
-
Publication number: 20110086897Abstract: A salt of (E)-N-{2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-be?zenesulfonyl]-1H-pyrrol-3-yl)-acrylamide selected from the group consisting of the hydrobromide, methansulfonate, hemi ethane-1,2-disulfonate, benzenesulfonate, toiuenesulfonate and 2-naphthalenesulfonate.Type: ApplicationFiled: March 11, 2009Publication date: April 14, 2011Applicant: 4SC AGInventors: Jürgen Volz, Martin Feth, Rolf-Peter Hummel, Matthias Muller, Thomas Maier, Bernd Muller
-
Publication number: 20100317565Abstract: The invention relates to novel peptides, which can be used for the production of pharmaceutical compositions. These pharmaceutical compositions can be used for the treatment of edema, in particular pulmonary edema.Type: ApplicationFiled: June 4, 2008Publication date: December 16, 2010Applicant: Rentschler Beteiligungs GmbHInventors: Dominik Geiger, Ingeborg Mühldorfer, Jürgen Paal, Klaus P. Schäfer, Jürgen Volz, Rudolf Lucas
-
Publication number: 20100120757Abstract: The compounds of a certain formula 1, in which R1, R7, R8, R9 and n have the meanings as given in the description, are novel effective inhibitors of the type 4 phosphodiesterase.Type: ApplicationFiled: May 14, 2008Publication date: May 13, 2010Applicant: NYCOMED GmbHInventors: Beate Schmidt, Christian Scheufler, Juergen Volz, Martin Feth, Rolf-Peter Hummel, Armin Hatzelmann, Christof Zitt, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley, Deborah Ockert, Anke Heuser, Johannes A.M. Christiaans, Geert Jan Sterk, Wiro M.P.B. Menge
-
Patent number: 5167934Abstract: The invention relates to a catalyzer installation for spark-ignition engines which are operated with air/fuel ratios of .lambda.1, particularly for boat engines, the catalyzer being subdivided into a reduction part located upstream in the exhaust gas line and an oxidation part located coaxially downstream after it. An intermediate space is located between the reduction and oxidation parts. Both catalyzer parts are surrounded by a preferably cylindrical, water-cooled casing and the casing has a downstream secondary air inlet to which a secondary air blower can be connected, the secondary air separating the very hot catalyzer from the double-walled, water-cooled casing and, in particular, flowing round the oxidation catalyzer part in counterflow for air preheating so that the air preheated in this manner is passed through the intermediate space into the oxidation part. The catalyzer is accommodated in a cartridge which is supported in wire compression rings in the catalyzer casing.Type: GrantFiled: June 16, 1989Date of Patent: December 1, 1992Assignee: KST-Motorenversuch GmbH & Co., KGInventors: Rainer Wolf, Juergen Volz, Peter Burghardt, Roland Sand
-
Patent number: 4869498Abstract: The present invention provides an isokinetic ergometer comprising a movement guide, power gripping points, a brake unit connected therewith and a speed regulator, characterized by the following features:(a) the power gripping points are mechanically connected with a piston movable in a cylinder,(b) a flow regulation valve is attached to the cylinder, and(c) the cylinder and flow regulation valve are hydraulically connected with one another via a pipe, the flow regulation valve regulating the length of the stroke.Type: GrantFiled: February 17, 1988Date of Patent: September 26, 1989Assignee: KST-Motorenversuch GmbH & Co. KGInventors: Rainer Wolf, Juergen Volz, Rainer Denkinger, Volker Nolte, Gerd Hussy